QDEL Q1 Earnings Call: Cost Savings and Tariff Mitigation Anchor 2025 Outlook
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) met Wall Street's revenue expectations in Q1 CY2025, but sales fell by 2.6% year on year to $692.8 million. The company's outlook for the full year was close to analysts' estimates with revenue guided to $2.71 billion at the midpoint. Its non-GAAP profit of $0.74 per share was 24.9% above analysts' consensus estimates.
Is now the time to buy QDEL? Find out in our full research report (it's free).
Revenue: $692.8 million vs analyst estimates of $689.8 million (2.6% year-on-year decline, in line)
Adjusted EPS: $0.74 vs analyst estimates of $0.59 (24.9% beat)
Adjusted EBITDA: $159.8 million vs analyst estimates of $149.4 million (23.1% margin, 7% beat)
The company reconfirmed its revenue guidance for the full year of $2.71 billion at the midpoint
Management reiterated its full-year Adjusted EPS guidance of $2.32 at the midpoint
EBITDA guidance for the full year is $595 million at the midpoint, in line with analyst expectations
Operating Margin: 4.7%, up from -247% in the same quarter last year
Market Capitalization: $2.09 billion
QuidelOrtho's first quarter results were shaped by growth in its core laboratories segment, stable immunohematology performance, and a robust flu testing season, offset by lower COVID-related and donor screening revenues. CEO Brian Blaser highlighted that the labs business, now over half of total revenue, delivered 7% year-over-year growth, while immunohematology grew 4%. Blaser credited the company's ongoing cost reduction initiatives—including staffing cuts and procurement efficiencies—for a 450 basis point improvement in adjusted EBITDA margin. The company also benefited from increased sales of its COVID-flu combination tests, which Blaser described as showing 'very stable performance,' helping mitigate the broader decline in COVID-only testing volumes. Management characterized the quarter as further evidence that its 2024 operational changes are positively impacting profitability and business stability.
Looking ahead, QuidelOrtho's management sees its narrowed set of strategic priorities—expanding platform content, margin improvement, and targeted commercial execution—as key drivers for 2025. Blaser emphasized the company's plans to fully offset anticipated tariff headwinds, noting, 'We believe the incremental actions we are taking are sufficient to fully offset the tariff impacts as they stand today.' The company expects recurring revenues from consumables to underpin stability, supported by a diversified manufacturing footprint. CFO Joe Busky added that visibility into labs and immunohematology growth in China supports a mid- to high-single-digit outlook for that market, assuming the tariff environment remains unchanged. Management remains focused on delivering cost savings and maintaining profitability targets, while monitoring for potential shifts in COVID and flu testing demand.
Management attributed the quarter's performance to solid growth in non-COVID segments, benefits from prior cost-reduction actions, and strong execution in the labs and flu testing businesses.
Labs business momentum: Core laboratories led growth, with consistent demand in clinical chemistry and immunoassay testing, representing over half of Q1 revenue.
Immunohematology stability: The immunohematology segment maintained its global leadership with steady 4% growth, particularly benefiting from strength in the Europe, Middle East, and Africa region.
Flu and combo testing resilience: Sales of flu tests and the COVID-flu combination test remained strong, offsetting the expected decline in pure COVID testing. The durability of the combo product contributed to recurring revenue streams.
Cost savings initiatives: Operational changes—including staff reductions, procurement efficiencies, and expense controls—were credited with expanding non-GAAP margins and reducing operating costs. Management expects further incremental savings in 2025.
Tariff mitigation efforts: The company outlined a multi-pronged strategy to counter expected $30–40 million tariff headwinds. Actions include re-sourcing materials, adjusting supply chains, selective pricing, and ongoing inventory repositioning. Management stated these steps are expected to fully neutralize tariff effects on financial results.
QuidelOrtho's outlook for 2025 is anchored by recurring revenue growth in core segments, ongoing cost control, and strategies to manage external headwinds such as tariffs.
Recurring consumables revenue: Management highlighted that over 90% of sales stem from consumables, providing a stable revenue foundation less susceptible to one-time instrument sales volatility. The company expects this model to drive consistent growth, especially in labs and immunohematology.
Cost discipline and savings: The company is on track to realize the remainder of its $100 million annualized cost savings program, with additional procurement and cash flow initiatives expected to deliver a further $30–50 million in savings during 2025. These efforts are intended to support margin expansion even as the company faces external cost pressures.
Tariff and macro environment management: Expected tariff headwinds are being addressed through supply chain adjustments, selective price increases, and cost reductions. Management expressed confidence that these measures will allow QuidelOrtho to maintain its guidance even if the tariff situation evolves, but noted that ongoing monitoring is required due to the dynamic nature of global trade policy.
In the coming quarters, the StockStory team will be watching (1) the pace at which cost savings and procurement initiatives translate into sustained margin gains, (2) the impact of tariff mitigation actions on both supply chain flexibility and pricing power, and (3) any changes in demand for respiratory testing—particularly the COVID-flu combination test. Progress on Savanna respiratory panel submission and broader product pipeline developments will also serve as key signposts for tracking execution.
QuidelOrtho currently trades at a forward P/E ratio of 12.1×. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it's free).
Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
an hour ago
- Axios
RFK Jr. blows up America's vaccine policy
America's vaccine policy has been set for decades, with patients, providers, scientists and insurers more or less in sync on the merits of immunizations. In the last several weeks, Health Secretary Robert F. Kennedy Jr. has upended long-standing norms, introducing uncertainty into a once-reliable system. Why it matters: Access to health care may shift in unpredictable ways. At worst, infectious diseases once thought to be eradicated could return. Catch up quick: Kennedy sent shockwaves through the medical community two weeks ago with a controversial decision to stop recommending the COVID vaccine to healthy kids and healthy pregnant women. The CDC contradicted this just days later, recommending that healthy kids do get the COVID shot. Confusion escalated this week, when Kennedy abruptly dismissed all 17 members of the expert panel that wields a great deal of power in shaping vaccine policy and makes recommendations to the CDC. Some of the eight new members Kennedy quickly named have expressed anti-vaccine sentiment in the past. Together, these changes represent a sharp break from public health precedent — and raise questions about what happens next. Case in point: Leigh Haldeman, a pregnant woman in Seattle, was recently turned away when going to get a COVID booster shot, as recommended by her doctor, CNN reports. Cases like hers could become more common. While most doctors and pharmacies will likely still be able to recommend and administer the vaccine, access might start to erode. Insurers are likely to start denying coverage of the COVID vaccine to groups who aren't deemed eligible by the government, putting the vaccine out of reach for people who don't have the time to seek out a willing provider or the money to pay out of pocket for the shot. The other side: Kennedy has said replacing the members of the expert panel is a "major step towards restoring public trust in vaccines." He's also said the decision to stop recommending COVID vaccines to kids is common sense because they're less likely to get very sick from COVID than adults. But the vaccine can still protect kids who could develop serious symptoms — and do so with no appreciable side effects, Chris Forrest, a professor of pediatrics at Children's Hospital of Philadelphia, told the New York Times. Zoom out: The COVID vaccine could just be the beginning. The CDC advisory panel members picked by Kennedy thus far are more aligned with his skeptical views of vaccines. They could radically reshape — or even scrap — national vaccine recommendations, including those for kids. They could also require more testing of new vaccines for safety and efficacy, which could have upstream effects — discouraging academic labs and drug companies from pursuing vaccine research and development. What to watch: Big changes in America's vaccine policy come amid a major cultural shift. Vaccine skepticism is on the rise, and more kindergartners are showing up to school with exemptions.
Business Insider
2 hours ago
- Business Insider
Zoom (ZM) Looks to Discover Former Glory as a Value Play with Rebounding Margins
Zoom Video Communications (ZM) is a prime example of a stock that went from being a huge winner during the pandemic stay-at-home boom to a forgotten ticker in just a few years. With triple-digit top-line growth during the pandemic, it was natural for growth rates—and the stock price—to slow down as the world returned to normal. Since COVID, ZM stock has flatlined. Confident Investing Starts Here: While investor enthusiasm has waned, Zoom's business hasn't collapsed; in fact, it has quietly evolved. The company managed to hold on to its customers, albeit at the cost of shrinking profit margins. Now, with margins making a solid comeback and strong cash flow and a healthy balance sheet in place, Zoom is starting to look less like a growth play and more like a value investor's favorite. Given its current valuation multiples and overall profile, I rate ZM as a Buy. Ultimately, this overlooked stock is worth keeping an eye on, given the potential catalysts on the horizon. A Fresh Look at Zoom About five years ago, Zoom was one of the hottest stocks during the pandemic, hitting a peak price of $500 in October 2020. The company's sales jumped from $622 million in 2021 to $2.6 billion in 2022 —a massive 325% increase in just one year. Since then, the stock has declined by approximately 85% from its peak. While it's virtually impossible to return to the dizzying heights of nearly five years ago, at current prices, Zoom could be an excellent value play. Even though Zoom's stock price took a big hit, its revenues didn't drop when the pandemic ended and work-from-home trends started to normalize. The company has been growing its revenue over the past three years, although not at the explosive pace it once achieved. Over the last twelve months, Zoom reported $4.7 billion in revenue, up from $4 billion in 2022. At the very least, Zoom has managed to retain some of the business it gained during the pandemic. In my opinion, much of this stability comes from building the leading video conferencing platform globally—one that's incredibly convenient compared to competitors and has created a loyal user base, especially in the corporate world. Additionally, as a software-based, cloud-native company with over 75% gross margins, Zoom converts a significant portion of its earnings into free cash flow. It also has a cash-rich balance sheet, holding approximately $7.8 billion in cash and equivalents, with virtually no debt. This cash alone represents roughly a third of its market capitalization. It's worth noting that when Zoom was trading at its peak, the company sold a bunch of equity, raising around $2.6 billion between 2020 and 2021. This resulted in shareholders being diluted by roughly 235% over the last five and a half years, which also significantly contributed to the substantial decline in stock value since the peak. Zoom's Still in the Room, Just Quieter While Zoom's top line hasn't declined since the pandemic started, the company has had to tighten its profit margins. With the post-COVID economic reopening, Zoom had to work harder to retain customers and negotiate better deals. As a result, operating margins dropped from over 30% at their peak to nearly 3% in 2023, before rebounding to around 20% today. This recovery is a solid achievement by the management team over the past couple of years. A significant part of that success stems from the long-term agreements Zoom has signed, as reflected in a growing remaining performance obligations (RPO) balance. Total RPOs grew 6% in the most recent quarter (1Q26), showing that Zoom isn't losing major customers but is actually expanding its corporate client base. In fact, 4,192 customers generated over $100,000 in revenue in the last twelve months—that's nearly 30% of the company's total revenue and the segment where Zoom earns its best operating margins. Additionally, Zoom has done a great job reducing churn rates, with the monthly average online churn dropping from 3.2% to 2.8% year-over-year. At the same time, the company has consistently cut costs, trimming expenses in Research and Development (R&D), marketing, and General and Administrative (G&A) areas by about 1% in the last quarter—actions that ultimately contributed to margin improvements in this slow-growth environment. Zoom Looks Undervalued for the Cash It Generates For its current fiscal year ending January 2026, Zoom is forecasting revenue growth of 2.6-2.8%, and free cash flow to shrink by about 2.5% at the midpoint of its guidance. These aren't exactly exciting numbers, but they do indicate solid customer retention and the business's maturity. Given that profile, I think Zoom trading at around 3.4x forward EV-to-revenue—roughly 15% above the industry average—but just 12.5x forward free cash flow (compared to an industry average of 19x) seems fair for a low-growth, value-oriented company. What makes it even more appealing is that over the last twelve years, Zoom has generated $1.78 billion in free cash flow. Based on its current enterprise value of $16.3 billion, that translates to a free cash flow yield of about 11%. For context, that's nearly double the S&P 500 (SPY) average, which typically ranges from 5–6%, and well above the 10-year Treasury yield at 4.5%. In other words, Zoom is generating solid returns, which seems definitely better than what investors would receive from risk-free options like government bonds. Is Zoom Video Communications Stock a Good Buy? While sentiment is mixed, the Wall Street consensus on Zoom Video Communications (ZM) is a Moderate Buy. Among the 24 analysts covering the stock over the past three months, 9 rate it a Buy, 13 recommend Hold, and only 1 suggests a Sell. ZM's average stock price target of $89.45 implies an upside potential of approximately 14.5% from the current share price. Zoom's Staying Steady and Turning Into a Value Play While Zoom is unlikely to replicate the explosive growth it saw during the pandemic, the company has proven its ability to retain customers, deliver steady growth in remaining performance obligations (RPOs), and monetize effectively, resulting in strong cash generation. Though it may no longer be a pure growth story, Zoom's pristine balance sheet and increasing free cash flow generation make its current valuation appear modest. As a result, the stock is increasingly taking shape as a compelling value play, and for now, I'm leaning bullish.
Time Business News
3 hours ago
- Time Business News
The Future of Business Finance: Trends, Tools, and Transformation
Business finance is undergoing a profound transformation. Once reliant on spreadsheets, ledgers, and in-person banking, modern financial management has embraced cloud computing, AI-driven analytics, digital currencies, and decentralized platforms. As businesses strive to stay competitive in a rapidly changing global economy, the tools and trends shaping finance are evolving at an unprecedented speed. This article explores the future of business finance by examining emerging trends, innovative tools, and the transformational shifts that are redefining how businesses operate and grow. Traditionally, business finance focused on managing capital, cash flow, investments, and risk. It was often siloed within accounting departments and disconnected from strategic decision-making. However, over the past decade, the role of finance has evolved into a more dynamic, technology-driven function central to corporate strategy. Today, financial leaders are expected to deliver real-time insights, align financial planning with long-term goals, and help navigate digital transformation. This shift is primarily powered by enterprise resource planning innovations and a growing recognition that finance is not just about numbers; it's about driving value. One of the most significant trends is the digitization of financial operations. Cloud-based financial software allows businesses to access data in real-time, automate processes, and improve collaboration across departments. Platforms like QuickBooks, Xero, and Oracle NetSuite offer integrated financial management systems for small and large enterprises alike. Cloud finance tools also reduce operational costs, improve data security, and enable remote financial oversight, benefits that became especially crucial during the COVID-19 pandemic. As businesses continue to decentralize and adopt hybrid work models, monitoring financial health digitally will remain essential. Artificial intelligence (AI) and automation are revolutionizing finance. Tools that once required manual data entry and analysis can now process invoices, track expenses, reconcile accounts, and generate financial reports automatically. Robotic process automation (RPA) is being used to streamline repetitive tasks, freeing up finance teams to focus on strategy and analysis. AI also enhances forecasting and budgeting by identifying patterns in financial data, predicting cash flow fluctuations, and providing scenario-based planning models. This level of precision and insight gives businesses a competitive edge in volatile markets. Fintech is no longer a niche; it's a mainstream driver of financial innovation. From peer-to-peer lending and digital banking to blockchain and crypto, fintech has introduced new ways for businesses to access capital, manage payments, and engage with customers. Small businesses, in particular, are benefiting from fintech platforms that provide faster loan approvals, lower fees, and simplified processes. Companies like Stripe, Square, and Revolut are redefining how businesses handle transactions and financial operations. Decentralized finance, or DeFi, is an emerging sector built on blockchain technology that allows businesses to perform financial transactions without traditional intermediaries. Through smart contracts and decentralized applications, companies can borrow, lend, and invest crypto assets securely and transparently. While still evolving and somewhat speculative, DeFi presents the potential to disrupt conventional finance, especially in areas where access to banking is limited. More businesses are exploring how digital assets like cryptocurrencies and tokenized assets can diversify their financial strategies and tap into new capital markets. Environmental, Social, and Governance (ESG) factors are becoming central to financial planning. Investors and stakeholders increasingly demand transparency on sustainability practices and ethical operations. Finance departments now play a key role in measuring ESG performance, allocating funds toward sustainable projects, and reporting on non-financial metrics. Sustainable finance tools help businesses align with regulatory standards, manage climate risk, and access ESG-linked financing options. This trend is not only good for the planet—it's good for business, as ESG-aligned companies often outperform their peers in long-term profitability. As the landscape of business finance evolves, a wide array of tools is emerging to support innovation and efficiency: Cloud ERP Systems : These integrate core business functions, including finance, HR, and supply chain, offering a single source of truth. : These integrate core business functions, including finance, HR, and supply chain, offering a single source of truth. AI-Powered Analytics : Tools like Microsoft Power BI and Tableau turn raw financial data into actionable insights. : Tools like Microsoft Power BI and Tableau turn raw financial data into actionable insights. Digital Payment Platforms : Services like PayPal, Stripe, and Square offer flexible, secure payment processing and are integrated with POS systems. : Services like PayPal, Stripe, and Square offer flexible, secure payment processing and are integrated with POS systems. Cryptocurrency Wallets and Exchanges : Tools like Coinbase and MetaMask allow businesses to hold and transact in digital currencies. : Tools like Coinbase and MetaMask allow businesses to hold and transact in digital currencies. Budgeting and Forecasting Software: Programs like Planful, Anaplan, and Float help businesses plan for future scenarios with data-driven precision. These tools not only increase efficiency but also provide agility, an essential asset in today's uncertain economic environment. The shift in finance isn't just about technology; it's also about people. As financial tools become more advanced, the skills required to manage them are changing. Financial professionals are expected to be tech-savvy, strategic, and data-literate. Finance teams are now partnering closely with IT, marketing, and operations to drive business goals. The role of the CFO is transforming from number cruncher to innovation leader—someone who bridges the gap between financial health and long-term strategy. Upskilling and reskilling will be critical. Businesses are investing in training programs that focus on data analytics, financial modeling, and digital literacy to ensure their finance teams are future-ready. While the future of business finance is promising, it also comes with challenges: Cybersecurity Risks : As more financial data moves online, the risk of cyberattacks increases. Businesses must invest in cybersecurity tools and protocols. : As more financial data moves online, the risk of cyberattacks increases. Businesses must invest in cybersecurity tools and protocols. Regulatory Compliance : New financial technologies bring regulatory uncertainty. Businesses need to stay informed on tax rules, data privacy laws, and financial reporting standards. : New financial technologies bring regulatory uncertainty. Businesses need to stay informed on tax rules, data privacy laws, and financial reporting standards. Integration Complexity : Implementing new tools can be disruptive. Integrating them with legacy systems requires time, planning, and technical expertise. : Implementing new tools can be disruptive. Integrating them with legacy systems requires time, planning, and technical expertise. Data Overload: With so much data available, businesses may struggle to extract meaningful insights without the right tools and talent. Despite these challenges, businesses that invest wisely in financial transformation will be better equipped to navigate disruption and seize new opportunities. The future of business finance is not just digital; it's intelligent, agile, and inclusive. From AI and blockchain to ESG and real-time analytics, the tools and trends shaping finance are driving a shift in how businesses think about money, value, and growth. Finance is no longer a back-office function. It is now a strategic enabler of innovation and resilience. Businesses that embrace these changes by adopting the right tools, developing new skills, and prioritizing compliance and sustainability will lead the next generation of growth in a fast-moving, tech-powered world. TIME BUSINESS NEWS
